Patent · US Active

Polymorphs of brimonidine pamoate

US8420648B2 · kind B2 · utility

0Cited by
14References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2011
Grant dateApr 16, 2013
Priority date
Expiry dateSep 15, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A brimonidine pamoate polymorph exhibits characteristics disclosed herein, wherein the brimonidine pamoate has the following formulaThe polymorph is included in a composition, device, or implant for use in the treatment or control of elevated intraocular pressure or in the neuroprotection of components of a neurological tissue to prevent progressive degeneration of such components. In particular, such a composition, device, or implant can be used to provide neuroprotection to cells and components of the optic nerve system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.